Skip to main content

Table 3 Differences between corticosteroid and immunosuppressive therapy use between rheumatological and dermatological centers of the DNSS

From: High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

Treatment

Rheumatological centers (%)

Dermatological centers (%)

P value

Corticosteroids

48.3 (360/746)

33.4 (217/650)

<0.0001

Immunosuppressants

45.6 (340/745)

24.5 (159/649)

<0.0001

Cyclophosphamide

21.5 (73/340)

23.9 (38/159)

 

Azathioprine

21.8 (74/340)

22.0 (35/159)

 

Methotrexate

35.9 (122/340)

18.9 (30/159)

<0.0001

(Hydroxy)chloroquine

8.8 (30/340)

3.8 (6/159)

<0.04

  1. DNSS, Deutsches Netzwerk für Systemische Sklerodermie (German Network for Systemic Scleroderma).